Next Generation News and Research

RSS

Non-sustained research on emerging infectious diseases endangers pandemic responses

Lack of Continuing Research Into Infectious Disease Epidemics Endangers Pandemic Responses, According to Ben-Gurion University Researchers

18 Aug 2020

Switching off 'master regulator' may protect critical brain cells from Parkinson's-related damage

Switching off a molecular "master regulator" may protect the brain from inflammatory damage and neurodegeneration in Parkinson's disease, reports a study published today in Nature Neuroscience.

17 Aug 2020

Wits University begins South African trial of Novavax COVID-19 vaccine

NVX-CoV2373 is produced by the biotech company, Novavax (Maryland, U.S.A). Novavax is a late-stage biotechnology company that develops next-generation vaccines for serious infectious diseases.

17 Aug 2020

Loughborough expert predicts how COVID-19 will impact the birth weight of babies

Being pregnant is a wonderful experience, but at the same it can be incredibly stressful - throw a global pandemic into the mix and those nine months may see an expecting mother go from happy and joyful, to fearful and concerned.

15 Aug 2020

Higher BCG vaccination coverage associated with improved COVID-19 outcomes

A tuberculosis vaccine administered during the past 15 years is associated with significantly improved COVID-19 outcomes, according to a new study published in Vaccines.

12 Aug 2020

Scientists design new catalyst to widen the range of target chemical substances for radical reactions

Organocatalysts consisting of organic compounds without metal elements are receiving much attention as next generation catalysts in the hope of reducing environmental burden and coping with exhaustion/rising prices of rare metals.

12 Aug 2020

Study to examine possible effects of COVID-19 on dementia risk in older adults

In addition to its clear impact on physical health, COVID-19 may also have adverse consequences for brain health. Therefore, researchers at Baycrest's Rotman Research Institute (RRI) are investigating the possible effects of COVID-19 and infection prevention measures on dementia risk in older adults.

11 Aug 2020

Quantum cryptographic communications technology can provide safe, secure data transmission in genomic medicine

Toshiba Corporation, Tohoku University Tohoku Medical Megabank Organization and Tohoku University Hospital have demonstrated that quantum cryptographic communications technology can provide genomic medicine with a safe, completely secure data management environment.

10 Aug 2020

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

A new study by researchers from the Scripps Research Institute and Novavax Inc. in the US affirms the structural integrity of the full-length SARS-CoV-2 spike glycoprotein immunogen. It enables the interpretation of immune responses to this multivalent nanoparticle immunogen. Their results are currently available on bioRxiv preprint server.

9 Aug 2020

FDA approves first companion diagnostic that uses liquid biopsy and NGS technology

Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).

7 Aug 2020

Swansea University tests new way to give vaccines through microneedle skin patches

A revolutionary new way to give vaccines through microneedle skin patches is being tested at Swansea University, thanks to £200,000 of EU funding announced by the Welsh Government.

7 Aug 2020

Study identifies five immune response markers that may predict COVID-19 patient outcomes

Galit Alter, PhD, Group Leader at the Ragon Institute of MGH, MIT and Harvard and Professor of Medicine at Harvard Medical School, and Helen Chu, MD, Associate Professor of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, and UW Medicine physician, have recently published a paper which identifies five immune response markers which, collectively, were able to correctly classify both convalescent COVID-19 patients and those who did not survive the disease.

7 Aug 2020

New document includes practical resources to improve diversity and inclusion in clinical research

The COVID-19 pandemic has illuminated social and health inequities and the impact of structural and systemic racism in society.

7 Aug 2020

Specifically designed cyclic peptide inhibitor shown to be active against SARS-CoV-2

A new bioRxiv study by a research group from the University of California Irvine shows in vitro activity and non-toxicity of the first-in-class cyclic peptide that inhibits the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – laying the groundwork for its use in the treatment of coronavirus disease (COVID-19).

4 Aug 2020

Next Generation News and Research

Non-sustained research on emerging infectious diseases endangers pandemic responses

Switching off 'master regulator' may protect critical brain cells from Parkinson's-related damage

Wits University begins South African trial of Novavax COVID-19 vaccine

Loughborough expert predicts how COVID-19 will impact the birth weight of babies

Higher BCG vaccination coverage associated with improved COVID-19 outcomes

Scientists design new catalyst to widen the range of target chemical substances for radical reactions

Study to examine possible effects of COVID-19 on dementia risk in older adults

Quantum cryptographic communications technology can provide safe, secure data transmission in genomic medicine

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

FDA approves first companion diagnostic that uses liquid biopsy and NGS technology

Swansea University tests new way to give vaccines through microneedle skin patches

Study identifies five immune response markers that may predict COVID-19 patient outcomes

New document includes practical resources to improve diversity and inclusion in clinical research

Specifically designed cyclic peptide inhibitor shown to be active against SARS-CoV-2

Researchers discover treatment for severe auto inflammatory syndrome

Researcher is exploring safer and more effective treatment for leukemia

Early blood test could detect birth asphyxia

Study reveals impact of TP53 gene mutations on MDS severity

A blood test may be an easy way to predict who will benefit from immunotherapy

Photonics-based device could help COVID-19 patients with adequate treatments

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News